Filter
440
Filtered Results: 440
Text search:
European
Centre
for
Disease
Prevention
and
Control
ECDC
Featured
Recommendations
41
New Publications
81
Language
Document type
No document type
184
Guidelines
83
Studies & Reports
80
Fact sheets
28
Manuals
20
Strategic & Response Plan
10
Situation Updates
9
Infographics
7
Resource Platforms
6
Training Material
5
Online Courses
4
Brochures
2
Videos
2
Countries / Regions
Western and Central Europe
81
Germany
18
Ukraine
18
Eastern Europe and Central Asia
16
Eastern Europe
16
Africa
7
Global
6
Guinea
5
Madagascar
5
West and Central Africa
5
Latin America and the Carribbean
5
Russia
5
Sierra Leone
4
Liberia
4
Brazil
4
Mozambique
3
Nigeria
2
Congo, Democratic Republic of
2
Guinea-Bissau
2
North Macedonia
2
Colombia
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Paraguay
2
Albania
2
Estonia
2
Romania
2
Spain
2
Burkina Faso
1
Senegal
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Cameroon
1
Ghana
1
Niger
1
Haiti
1
South Sudan
1
Turkey
1
Rwanda
1
Benin
1
Libya
1
Angola
1
South–East Asia Region
1
Western Pacific Region
1
Asia
1
Venezuela
1
Italy
1
Armenia
1
Congo-Brazzaville
1
Tajikistan
1
Bulgaria
1
Moldova
1
Uzbekistan
1
Georgia
1
Turkmenistan
1
Denmark
1
France
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
81
Clinical Guidelines
20
Key Resources
19
Public Health
11
Capacity Building
3
Women & Child Health
2
Pharmacy & Technologies
1
Toolboxes
COVID-19
90
HIV
58
AMR
57
Rapid Response
56
TB
47
Zika
25
Ebola
24
Refugee
21
Conflict
18
Planetary Health
12
Mental Health
6
Global Health Education
4
NTDs
4
Specific Hazards
3
Cholera
2
Caregiver
2
Pharmacy
2
Polio
1
Natural Hazards
1
Health Financing Toolbox
1
Resources and Situation Updates COVID-19
This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air...
8 March 2022
A very large number of people from Ukraine are fleeing the country and entering the European Union (EU) countries bordering Ukraine (Hungary, Poland, Romania, Slovakia) ... the EU-neighbourhood country of the Republic of Moldova. Those fleeing Ukraine - mainly women and children - are currently dispersing into communities, but as more people congregate at border crossings it is likely that they will also need to be housed in reception centres.
ECDC Technical Report, Fourth Update 3 July 2020
This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), ... can be adapted depending on the assessed severity/impact of the infection. Other measures are valid for all phases of an epidemic.
The guidance is based on the current knowledge of the 2019-nCoV and evidence available on other viral respiratory pathogens, mainly the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), the Middle East Respiratory Syndrome-related coronavirus (MERS-CoV) and seasonal or pandemic influenza viruses.
This document provides guidance on infection prevention and control (IPC) measures for people wi...
Infection prevention and control (IPC) practices are of critical importance in protecting the function of healthcare services at all levels ... mitigating the impact on vulnerable populations. Although the management of possible COVID-19 cases is usually guided by national policies for specific healthcare facilities, community transmission is currently widespread in most EU/EEA countries and the UK, therefore primary healthcare providers in the community such as GPs, dentists and pharmacists are at risk of being exposed to COVID-19.
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) ... the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-19 in healthcare settings, including long-term care facilities (LTCFs). In addition, this document addresses the management of clinical diagnostic specimens at laboratories in the EU/EEA. This is the sixth update of the ECDC guidance on ‘Infection prevention and control and preparedness for COVID-19 in healthcare settings’, and replaces the document dated 6 October 2020.
This document offers public health guidance for the prevention and control of COVID-19 in recept...
7 April 2022. Aimed at national policymakers, public health and healthcare planners, staff working in reception centres, and healthcare staff caring for...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the <... remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improve leishmaniasis prevention and control based on robust surveillance in humans, animals, and vectors, and to increase public awareness following a one health approach.
ummer is here and there are a lot of great opportunities for people to gather and enjoy themselves. Public health authorities are working together ...
Preparedness planning is essential in order to respond effectively to outbreaks, including single case occurrences of highconsequence infectious diseases (HCID), such as the importation of a viral haemorrhagic fever (VHF) case
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans ... food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, expressed in mg/kg of estimated biomass, were compared at country and European level. Substantial variations between countries were observed in both sectors. Estimated data on AMC for pigs and poultry were used for the first time. Univariate and multivariate analyses were applied to study associations between AMC and AMR. In 2014, the average AMC was higher in animals (152 mg/kg) than in humans (124 mg/kg), but the opposite applied to the median AMC (67 and 118 mg/kg, respectively). In 18 of 28 countries, AMC was lower in animals than in humans. Univariate analysis showed statistically-significant (p < 0.05) associations between AMC and AMR for fluoroquinolones and Escherichia coli in both sectors, for 3rd- and 4th-generation cephalosporins and E. coli in humans, and tetracyclines and polymyxins and E. coli in animals. In humans, there was a statistically-significant association between AMC and AMR for carbapenems and polymyxins in Klebsiella pneumoniae. Consumption of macrolides in animals was significantly associated with macrolide resistance in Campylobacter coli in animals and humans. Multivariate analyses provided a unique approach to assess the contributions of AMC in humans and animals and AMR in bacteria from animals to AMR in bacteria from humans. Multivariate analyses demonstrated that 3rd- and 4th-generation cephalosporin and fluoroquinolone resistance in E. coli from humans was associated with corresponding AMC in humans, whereas resistance to fluoroquinolones in Salmonella spp. and Campylobacter spp. from humans was related to consumption of fluoroquinolones in animals. These results suggest that from a ‘One-health’ perspective, there is potential in both sectors to further develop prudent use of antimicrobials and thereby reduce AMR.
Guidance Brief
Selected findings from ECDC and EMCDDA scientific guidance, 2018
